Prominent Exocrine Pancreatic Insufficiency Market Trend for 2025: Exocrine Pancreatic Insufficiency Market Grows With Patient Advocacy And Nutritional Support Initiatives

What Are the Projected Growth and Market Size Trends for the Exocrine Pancreatic Insufficiency Market?
The exocrine pancreatic insufficiency market has seen strong growth in recent years. It is projected to increase from $2.59 billion in 2024 to $2.76 billion in 2025, at a compound annual growth rate (CAGR) of 6.6%. The growth is driven by factors such as increased awareness and diagnosis, the rising prevalence of digestive disorders, an aging population, a decline in pancreatic function, and the rise in gastrointestinal surgeries.

The exocrine pancreatic insufficiency market is expected to grow robustly, reaching $3.58 billion by 2029 at a CAGR of 6.7%. This growth is attributed to increased awareness and screening, an expanding geriatric population, the rising prevalence of chronic diseases, better healthcare access, and advancements in digestive health research. Trends include telehealth and digital health solutions, collaborative research, a focus on pediatric EPI, regulatory advances, and market growth in emerging economies.

What Is Driving the Growth Trajectory of the Exocrine Pancreatic Insufficiency Market?
The rise in chronic diseases is expected to stimulate growth in the exocrine pancreatic insufficiency market. Chronic diseases are long-term conditions that persist for months or years. Their prolonged presence increases the likelihood of complications such as exocrine pancreatic insufficiency, prompting improved management through medical interventions, which can extend life expectancy for affected individuals. For instance, in September 2023, the World Health Organization reported that non-communicable diseases (NCDs) caused 74% of 41 million global deaths each year. Consequently, the rise in chronic diseases is expected to drive the growth of the exocrine pancreatic insufficiency market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp

Which Leading Companies Are Shaping the Growth of the Exocrine Pancreatic Insufficiency Market?
Major companies operating in the exocrine pancreatic insufficiency market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Nestle Health Science S.A., Allergan PLC, Chiesi Farmaceutici S.p.A., Wockhardt Ltd., Amryt Pharma PLC, Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, Aimmune Therapeutics Inc., Digestive Care Inc., Enzymedica Inc., Vivus Inc., Alcresta Therapeutics Inc., Cilian AG, Perseo Pharma AG, Enzyme Development Corporation, First Wave BioPharma Inc., Synspira Therapeutics

What Are the Major Trends Shaping the Exocrine Pancreatic Insufficiency Market?
Leading companies in the exocrine pancreatic insufficiency market are focusing on building patient advocacy groups that provide comprehensive nutritional guidance and support. These initiatives aim to raise awareness, educate, and assist those affected by the condition. A holistic approach to nutritional guidance tailors dietary recommendations based on individual needs and health conditions, emphasizing education, meal planning, and sustainable practices. For example, in June 2024, Nestlé Health Science, a Switzerland-based nutrition company, launched a GLP-1 nutrition support platform. This platform provides personalized nutritional resources and expert guidance for individuals using GLP-1 medications, with a focus on muscle preservation, gut health, and overall wellness, helping users manage their weight through dietary solutions and community support.

What Are the Key Segments of the Exocrine Pancreatic Insufficiency Market?
The exocrine pancreatic insufficiency market covered in this report is segmented -

1) By Treatment: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments
2) By Diagnosis: Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-1), Other Types
3) By Symptoms: Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End Users: Hospitals, Specialty Clinics, Homecare

Subsegments:
1) By Nutritional Management: Dietary Modifications, Nutritional Supplements
2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules, Non-Enteric-Coated Capsules, Powder Formulations
3) By Other Treatments: Medications, Surgical Interventions, Supportive Therapies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

Which Region Dominates the Exocrine Pancreatic Insufficiency Market?
North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Exocrine Pancreatic Insufficiency Global Market Report?

- Market Size Analysis: Analyze the Exocrine Pancreatic Insufficiency Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Exocrine Pancreatic Insufficiency Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Exocrine Pancreatic Insufficiency Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Exocrine Pancreatic Insufficiency Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13107

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.